NewGenIvf (NIVF) EBITDA Margin (2024 - 2025)
NewGenIvf (NIVF) reported EBITDA Margin of 531.42% for Q4 2025, down 52849.0% year-over-year from N/an in Q4 2024, and down 141.57% quarter-over-quarter from 1278.22% in Q3 2025.
NewGenIvf (NIVF) EBITDA Margin (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of EBITDA Margin data on file, last reported at 531.42% in Q4 2025.
- EBITDA Margin for Q4 2025 came in at 531.42%, down 52849.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 157.23% (changed N/A YoY), and the FY2025 annual result was 201.12%, up 20925.0% from the prior year.
- EBITDA Margin slipped to 531.42% in Q4 2025 per NIVF's latest filing, from 1278.22% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1278.22% in Q3 2025 and troughed at 531.42% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 4,926.74% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 15.04% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.45% |
| 10 | NewGenIvf | - | - | 524,025.00 | -531.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -531.42% |
| Sep 30, 2025 | 1,278.22% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | -14.14% |